Clinical Trials Browser

Phase 2 × UNKNOWN × Biliary Tract Neoplasms × Clear all

NCT03830606 2021-02-01

The Efficacy and Safety of Nab-paclitaxel Plus S-1 in First-line Treatment of Advanced Biliary Tract Adenocarcinoma

Phase 2 Completed

Gastrointestinal

Biliary Tract Neoplasms